Dipongkor Saha

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Pulmonary Artery

Herpes Simplex Virus

Polycyclic Aromatic Hydrocarbons

Vascular Endothelial Growth Factor

Top Venues

Journal for immunotherapy of cancer

Stem cell reviews and reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hongbin Wang, Mia Borlongan, Howard L Kaufman, Uyen Le, Hans J Nauwynck, Samuel D Rabkin, Dipongkor Saha
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? Journal for immunotherapy of cancer 12 (5) (2024)
Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for immunotherapy of cancer 12 (4) (2024)
Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for immunotherapy of cancer 12 (4) (2024)
Hongbin Wang, Mia Borlongan, Howard L Kaufman, Uyen Le, Hans J Nauwynck, Samuel D Rabkin, Dipongkor Saha
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? Journal for immunotherapy of cancer 12 (5) (2024)
Hongbin Wang, Mia Borlongan, Howard L Kaufman, Uyen Le, Hans J Nauwynck, Samuel D Rabkin, Dipongkor Saha
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? Journal for immunotherapy of cancer 12 (5) (2024)
Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for immunotherapy of cancer 12 (4) (2024)
Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for immunotherapy of cancer 12 (4) (2024)
Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for immunotherapy of cancer 12 (4) (2024)
Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, Howard L Kaufman, Samuel D Rabkin, Dipongkor Saha
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival. Journal for immunotherapy of cancer 12 (4) (2024)
Mia C Borlongan, Dipongkor Saha, Hongbin Wang
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy. Stem cell reviews and reports (2023)
Trieu Nguyen, Linh Ho, Sakib M Moinuddin, Tanoy Sarkar, Dipongkor Saha, Fakhrul Ahsan
Multicellular Cell Seeding on a Chip: New Design and Optimization towards Commercialization. Biosensors 12 (8) (2022)
Tanoy Sarkar, Trieu Nguyen, Sakib M Moinuddin, Kurt R Stenmark, Eva S Nozik, Dipongkor Saha, Fakhrul Ahsan
A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device. Micromachines 13 (9) (2022)
Trieu Nguyen, Tanoy Sarkar, Tuan Tran, Sakib M Moinuddin, Dipongkor Saha, Fakhrul Ahsan
Multilayer Soft Photolithography Fabrication of Microfluidic Devices Using a Custom-Built Wafer-Scale PDMS Slab Aligner and Cost-Efficient Equipment. Micromachines 13 (8) (2022)
Hong-My Nguyen, Dipongkor Saha
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment. Oncolytic virotherapy 10 (2021)
Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B Lowe, Dipongkor Saha
Pathogenetic Features and Current Management of Glioblastoma. Cancers 13 (4) (2021)
Dipongkor Saha, Samuel D Rabkin, Robert L Martuza
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma. Journal for immunotherapy of cancer 8 (1) (2021)